Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Naik

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|November 28, 2022
Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AMLThomas Pfeiffer, Ying Li, Emily Ashcraft, et al.
Blood Advances|November 22, 2023
Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learningYiwang Zhou, Jesse Smith, Dinesh Keerthi, et al.
European Journal of Medical Genetics|February 1, 2023
Expanding the phenotypic spectrum of Chromosome 16p13.11 microduplication: A multicentric analysis of 206 patientsAsma Hamad, Charlotte A Sherlaw-Sturrock, Kate Glover, et al.
Blood Immunology & Cellular Therapy|June 26, 2026
Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patientsShruthi Suryaprakash, Yilun Sun, Dinesh Keerthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT SettingThomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, et al.
Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.
Cytotherapy|June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumorsDevin Murphy, Yu Bi, Aysha Patel, et al.
Cytotherapy|July 24, 2024
Safety and Efficacy of High-Dose Memory CD45RO<sup>+</sup> Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell TransplantationMercedes Gasior Kabat, Ying Li, Victor Galán, et al.
Blood|May 16, 2015
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantationXiaoou Zhou, Gianpietro Dotti, Robert A Krance, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|November 28, 2022
Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AMLThomas Pfeiffer, Ying Li, Emily Ashcraft, et al.
Blood Advances|November 22, 2023
Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learningYiwang Zhou, Jesse Smith, Dinesh Keerthi, et al.
European Journal of Medical Genetics|February 1, 2023
Expanding the phenotypic spectrum of Chromosome 16p13.11 microduplication: A multicentric analysis of 206 patientsAsma Hamad, Charlotte A Sherlaw-Sturrock, Kate Glover, et al.
Blood Immunology & Cellular Therapy|June 26, 2026
Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patientsShruthi Suryaprakash, Yilun Sun, Dinesh Keerthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2023
Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT SettingThomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, et al.
Hemasphere|December 10, 2025
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statementAdam Lamble, Sandra D Bohling, Kara L Davis, et al.
Cytotherapy|June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumorsDevin Murphy, Yu Bi, Aysha Patel, et al.
Cytotherapy|July 24, 2024
Safety and Efficacy of High-Dose Memory CD45RO<sup>+</sup> Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell TransplantationMercedes Gasior Kabat, Ying Li, Victor Galán, et al.
Blood|May 16, 2015
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantationXiaoou Zhou, Gianpietro Dotti, Robert A Krance, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2017
Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich SyndromeAlexander Ngwube, I Celine Hanson, Jordan Orange, et al.
Pageof 10